Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
Cephalon
is defunct.
Acquired by Teva, Oct 2011, $6.8B
------------------
If you believe any of this information is incorrect, please
let us know
.